Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,373,886
  • Shares Outstanding, K 177,684
  • Annual Sales, $ 1,767 M
  • Annual Income, $ -595,630 K
  • 60-Month Beta 1.31
  • Price/Sales 4.29
  • Price/Cash Flow N/A
  • Price/Book 2.43
Trade EXAS with:

Options Overview Details

View History
  • Implied Volatility 125.95% ( -2.35%)
  • Historical Volatility 72.12%
  • IV Percentile 99%
  • IV Rank 96.97%
  • IV High 128.30% on 11/28/22
  • IV Low 50.87% on 08/10/22
  • Put/Call Vol Ratio 0.75
  • Today's Volume 6,208
  • Volume Avg (30-Day) 4,065
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 85,559
  • Open Int (30-Day) 83,251

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -1.03
  • Number of Estimates 8
  • High Estimate -0.93
  • Low Estimate -1.15
  • Prior Year -1.28
  • Growth Rate Est. (year over year) +19.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.43 +31.05%
on 11/03/22
48.26 -14.65%
on 11/11/22
+6.61 (+19.12%)
since 10/28/22
3-Month
29.27 +40.72%
on 10/13/22
48.26 -14.65%
on 11/11/22
+5.49 (+15.38%)
since 08/29/22
52-Week
29.27 +40.72%
on 10/13/22
89.99 -54.23%
on 11/30/21
-44.27 (-51.80%)
since 11/26/21

Most Recent Stories

More News
Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 44%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 43.9% in Exact Sciences (EXAS). While the effectiveness of this highly sought-after metric is questionable, the...

EXAS : 41.19 (-0.75%)
3 Healthcare Stocks That Could Set You Up For Life

All offer products that are invaluable to their respective audiences.

VEEV : 182.44 (-2.27%)
EXAS : 41.19 (-0.75%)
NVO : 121.35 (+0.10%)
Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 85%: Here's is How to Trade

The mean of analysts' price targets for Exact Sciences (EXAS) points to an 84.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

EXAS : 41.19 (-0.75%)
Why Exact Sciences Stock Is Soaring Today

Investors are reacting positively to the company's Q3 update.

EXAS : 41.19 (-0.75%)
Exact Sciences (EXAS) Q3 Earnings Top Estimates, Margin Falls

Exact Sciences (EXAS) registers robust revenues from the Screening and Precision Oncology segments in Q3.

MMSI : 70.13 (-0.04%)
EXAS : 41.19 (-0.75%)
MEDP : 207.24 (-2.54%)
ELV : 515.36 (+0.50%)
Exact Sciences (EXAS) Q3 2022 Earnings Call Transcript

EXAS earnings call for the period ending September 30, 2022.

EXAS : 41.19 (-0.75%)
Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of 23.64% and 4.45%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EXAS : 41.19 (-0.75%)
VTVT : 0.8410 (+0.72%)
Exact Sciences: Q3 Earnings Snapshot

Exact Sciences: Q3 Earnings Snapshot

EXAS : 41.19 (-0.75%)
Mirati (MRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Mirati (MRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MRTX : 88.76 (-7.22%)
EXAS : 41.19 (-0.75%)
Exact Sciences to participate in November investor conferences

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...

EXAS : 41.19 (-0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 43.41
2nd Resistance Point 42.78
1st Resistance Point 41.99
Last Price 41.19
1st Support Level 40.56
2nd Support Level 39.93
3rd Support Level 39.14

See More

52-Week High 89.99
Fibonacci 61.8% 66.79
Fibonacci 50% 59.63
Fibonacci 38.2% 52.47
Last Price 41.19
52-Week Low 29.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar